目的：探讨尿激酶溶栓治疗的时间窗。
Objective: To investigate the time window of urokinase thrombolysis.
结论动脉溶栓治疗脑梗塞，动脉内溶栓时间窗与多种因素密切相关。
Conclusion in treating acute cerebral infarction using intra-arterial thrombolysis, the therapeutic time window is closely related to a lot of factors.
另外，对所谓的溶栓治疗中风(其中药品是用来溶解血液凝块一)必须给予三个月内发生中风的时间。
Also, one of the treatments for strokes called thrombolysis (where medicines are used to dissolve blood clots) must be given within three hours of the stroke happening.
近年来的研究表明，溶栓治疗的时间窗应个体化。
The recent studies have shown that the therapeutic time window (TTW) for thrombolytic therapy should be individualized.
目的：观察急性心肌梗死(ami)发病后不同时间溶栓治疗对血管再通的影响。
Objective: To study the effect of thrombolytic therapy on blood vessel reperfusion by different times after acute myocardial infarction (AMI).
目的研究急性ST段抬高心肌梗死（STEMI）发病后不同时间溶栓治疗对血管再通的影响。
Objective To study the effect of thrombolytic therapy on blood vessel reperfusion in different times after ST-segment elevation myocardial infarction (STEMI).
目的：研究急性心肌梗死(ami)发病后不同时间溶栓治疗对血管再通的影响。
Objective: To study the effect of thrombolytic therapy on blood vessel reperfusion in different times after acute myocardial infarction (AMI).
结论尿激酶溶栓时间越早，再通率越高，是一种治疗ami平安、有效的抢救措施。
Conclusions the urokinase thrombolysis time more early, again passes rate is higher, is one kind treats the AMI security, the effective rescue measure.
目的旨在探讨静脉溶栓治疗急性缺血性脑卒中的最佳治疗时间窗。
Objective To determine the most optional treatment time window for intravenous thrombolysis of acute ischemic stroke.
究其原因主要是由于超早期诊断困难，溶栓及神经保护治疗的个体时间窗不明和缺乏特效的药物。
The reason lies in the difficulty of super early diagnosis, insensibility of the window time of nerve protective therapy, dissolution of thrombus and absence of special effective drugs.
目的：探讨急性心肌梗死(ami)后不同时间溶栓治疗对血管再通的影响。
Objective: To investigate the effect of revascularization in the different time after acute myocardial infarction (AMI) treated by thrombolysis.
文章对动脉内溶栓治疗的时间窗、治疗前评价、病例和药物选择等研究现状做了综述。
This article reviews the study status quo of the time window, pretreatment assessment, and selection of patients and drugs for intra-arterial thrombolysis.
结论体外治疗性超声能促进血栓溶解，缩短再通时间，提高溶栓的成功率。
Conclusion ETUS can accelerate thrombolysis, shorten recanalization time and enhance the successful rate of thrombolysis.
目的：探讨小剂量尿激酶超时间窗静脉溶栓治疗急性脑梗死的疗效及安全性。
Objective: To determine the clinical curative effect and safety of intravenous thrombolytic therapy with low dose urokinase for the acute cerebral infarction.
溶栓治疗有时间限制，而无时间限制的神经保护治疗也陷入了困境。
Thrombolytic therapy is restricted to the time-window, while neuroprotective drugs, despite its unlimited time constraints, are also stuck.
在入院前进行溶栓治疗时初次治疗所花费的时间是31分钟，而入院后接受治疗的患者则要64分钟。
Time to initial treatment averaged 31 minutes for pre-hospital thrombolysis, compared with 64 minutes for patients who started treatment at a hospital.
在入院前进行溶栓治疗时初次治疗所花费的时间是31分钟，而入院后接受治疗的患者则要64分钟。
Time to initial treatment averaged 31 minutes for pre-hospital thrombolysis, compared with 64 minutes for patients who started treatment at a hospital.
应用推荐